Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Babjuk

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Cancer Letters|December 14, 2005
Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancerMarie Trkova, Marko Babjuk, Jaroslava Duskova, et al.
European Urology|April 28, 2016
The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year ResultsSeiji Naito, Ferran Algaba, Marko Babjuk, et al.
European Urology|September 18, 2012
Smoking reduces the efficacy of intravesical bacillus Calmette-Guérin immunotherapy in non-muscle-invasive bladder cancerMichael Rink, Evanguelos Xylinas, Marko Babjuk, et al.
European Urology Oncology|July 21, 2020
Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder TumoursHugh Mostafid, Ashish M Kamat, Siamak Daneshmand, et al.
European Urology|May 22, 2012
Follow-up after surgical treatment of bladder cancer: a critical analysis of the literatureViktor Soukup, Marko Babjuk, Joaquim Bellmunt, et al.
BJU International|May 29, 2018
A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimensAndrea Mari, Shoji Kimura, Beat Foerster, et al.
Anticancer Research|May 1, 2007
Simultaneous proteomic and genomic analysis of primary Ta urothelial cell carcinomas for the prediction of tumor recurrenceIman J Schultz, Jacques B De Kok, J Alfred Witjes, et al.
European Urology|August 3, 2013
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literatureMichael Rink, Marko Babjuk, James W F Catto, et al.
European Urology|December 13, 2016
Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61Marko Babjuk, Maximilian Burger, Eva Compérat, et al.
Urologic Oncology|March 7, 2015
Urethral recurrence in women with orthotopic bladder substitutes: A multi-institutional studyGeorgios Gakis, Bedeir Ali-El-Dein, Marko Babjuk, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Cancer Letters|December 14, 2005
Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancerMarie Trkova, Marko Babjuk, Jaroslava Duskova, et al.
European Urology|April 28, 2016
The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year ResultsSeiji Naito, Ferran Algaba, Marko Babjuk, et al.
European Urology|September 18, 2012
Smoking reduces the efficacy of intravesical bacillus Calmette-Guérin immunotherapy in non-muscle-invasive bladder cancerMichael Rink, Evanguelos Xylinas, Marko Babjuk, et al.
European Urology Oncology|July 21, 2020
Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder TumoursHugh Mostafid, Ashish M Kamat, Siamak Daneshmand, et al.
European Urology|May 22, 2012
Follow-up after surgical treatment of bladder cancer: a critical analysis of the literatureViktor Soukup, Marko Babjuk, Joaquim Bellmunt, et al.
BJU International|May 29, 2018
A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimensAndrea Mari, Shoji Kimura, Beat Foerster, et al.
Anticancer Research|May 1, 2007
Simultaneous proteomic and genomic analysis of primary Ta urothelial cell carcinomas for the prediction of tumor recurrenceIman J Schultz, Jacques B De Kok, J Alfred Witjes, et al.
European Urology|August 3, 2013
Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literatureMichael Rink, Marko Babjuk, James W F Catto, et al.
European Urology|December 13, 2016
Reply to Harry Herr's Letter to the Editor re: Marko Babjuk, Andreas Böhle, Maximilian Burger, et al. EAU Guidelines on Non-muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol 2017;71:447-61Marko Babjuk, Maximilian Burger, Eva Compérat, et al.
Urologic Oncology|March 7, 2015
Urethral recurrence in women with orthotopic bladder substitutes: A multi-institutional studyGeorgios Gakis, Bedeir Ali-El-Dein, Marko Babjuk, et al.
Pageof 12